相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Patient reported outcomes in adults with type 2 diabetes on basal insulin randomized to addition of mealtime pramlintide or rapid-acting insulin analogs
Mark Peyrot et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Comparison of the Post-Meal Glucose Response to Different Insulin Bolus Waveforms in Insulin Pump- and Pre-Meal Pramlintide-Treated Type 1 Diabetes Patients
Allen B. King
DIABETES TECHNOLOGY & THERAPEUTICS (2010)
The role for saxagliptin within the management of type 2 diabetes mellitus: an update from the 2010 European Association for the Study of Diabetes (EASD) 46th annual meeting and the American Diabetes Association (ADA) 70th scientific session
Pablo J. Aschner
DIABETOLOGY & METABOLIC SYNDROME (2010)
Pharmacologic Management of the Older Patient With Type 2 Diabetes Mellitus
Joshua J. Neumiller et al.
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (2009)
Randomized Comparison of Pramlintide or Mealtime Insulin Added to Basal Insulin Treatment for Patients With Type 2 Diabetes
Matthew Riddle et al.
DIABETES CARE (2009)
Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trial
Itamar Raz et al.
DIABETES CARE (2009)
MINIMAL REDUCTION IN INSULIN DOSAGE WITH PRAMLINTIDE THERAPY WHEN PRETREATMENT NEAR-NORMAL GLYCEMIA IS ESTABLISHED AND SQUARE-WAVE MEAL BOLUS IS USED
Allen B. King
ENDOCRINE PRACTICE (2009)
CONTINUOUS SUBCUTANEOUS PRAMLINTIDE INFUSION THERAPY IN PATIENTS WITH TYPE 1 DIABETES: OBSERVATIONS FROM A PILOT STUDY
David M. Huffman et al.
ENDOCRINE PRACTICE (2009)
Pramlintide Lowered Glucose Excursions and Was Well-Tolerated in Adolescents with Type 1 Diabetes: Results from a Randomized, Single-Blind, Placebo-Controlled, Crossover Study
H. Peter Chase et al.
JOURNAL OF PEDIATRICS (2009)
Efficacy and safety of incretin-based therapies: Clinical trial data
John White
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2009)
Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy
Eric Ravussin et al.
OBESITY (2009)
Reducing postprandial hyperglycemia with adjuvant premeal pramlintide and postmeal insulin in children with type 1 diabetes mellitus
Krishnavathana Hassan et al.
PEDIATRIC DIABETES (2009)
Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, parallel-group study
Thomas J. Moretto et al.
CLINICAL THERAPEUTICS (2008)
Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity
Steve R. Smith et al.
DIABETES CARE (2008)
Optimizing treatment success with an amylin analogue
Laura L. Want
DIABETES EDUCATOR (2008)
Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies
Jonathan D. Roth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The role of prandial pramlintide in the treatment of adolescents with type 1 diabetes
Luisa M. Rodriguez et al.
PEDIATRIC RESEARCH (2007)
Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes using basal insulin
Matthew Riddle et al.
DIABETES CARE (2007)
Nateglinide reduces carotid intima-media thickening in type 2 diabetic patients under good glycemic control
Tomoya Mita et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Systematic review: Comparative effectiveness and safety of oral medications for type 2 diabetes Mellitus
Shari Bolen et al.
ANNALS OF INTERNAL MEDICINE (2007)
Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes -: Importance of postprandial glycemia to achieve target HbA1c levels
Hans J. Woerle et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: A phase 2, randomized, placebo-controlled, dose-escalation study
Louis Aronne et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Pharmacokinetics of an oral drug (Acetaminophen) administered at various times relative to subcutaneous injection of pramlintide in subjects with type 2 diabetes
Terrie A. Kellmeyer et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Effects of nateglinide and glibenclamide on prothrombotic factors in naive type 2 diabetic patients treated with metformin: A 1-year, double-blind, randomized clinical trial
Giuseppe Derosa et al.
INTERNAL MEDICINE (2007)
A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education
Diane Wild et al.
PATIENT EDUCATION AND COUNSELING (2007)
Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187
Bronislava R. Gedulin et al.
REGULATORY PEPTIDES (2006)
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus
I. Raz et al.
DIABETOLOGIA (2006)
A double-blind, placebo-controlled trial assessing pramlintide treatment in the setting of intensive insulin therapy in type 1 diabetes
Steve Edelman et al.
DIABETES CARE (2006)
Recovery and purification of highly aggregation-prone disulfide-containing peptides: Application to islet amyloid polypeptide
A Abedini et al.
ANALYTICAL BIOCHEMISTRY (2006)
Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic Hyperglycemia in patients with type 2 diabetes
L Monnier et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: A randomized crossover study
M Shimabukuro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: Lessons from the San Luigi Gonzaga Diabetes Study
F Cavalot et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality - Data from the Baltimore Longitudinal Study of Aging with a critical review of the literature
JD Sorkin et al.
DIABETES CARE (2005)
The effect of pramlintide on hormonal, metabolic or symptomatic responses to insulin-induced hypoglycaemia in patients with type 1 diabetes
SA Amiel et al.
DIABETES OBESITY & METABOLISM (2005)
Insulin-induced hypoglycemia accelerates gastric emptying of solids and liquids in long-standing type 1 diabetes
A Russo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes
I Chapman et al.
DIABETOLOGIA (2005)
The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes
RA Heptulla et al.
DIABETES (2005)
Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance
M Hanefeld et al.
STROKE (2004)
Effect of pramlintide on symptom, catecholamine, and glucagon responses to hypoglycemia in healthy subjects
T Heise et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus
K Esposito et al.
CIRCULATION (2004)
Amylin agonists: A novel approach in the treatment of diabetes
O Schmitz et al.
DIABETES (2004)
Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial
RE Ratner et al.
DIABETIC MEDICINE (2004)
Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study
DG Maggs et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2004)
Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance - The STOP-NIDDM Ttrial
JL Chiasson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes - A 1-year randomized controlled trial
PA Hollander et al.
DIABETES CARE (2003)
Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes - A dose-timing study
C Weyer et al.
DIABETES CARE (2003)
Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans - Role of oxidative stress
K Esposito et al.
CIRCULATION (2002)
The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus
M Fineman et al.
HORMONE AND METABOLIC RESEARCH (2002)
The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type I diabetes
MS Fineman et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2002)
A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes
F Whitehouse et al.
DIABETES CARE (2002)
Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus
A Vella et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2002)
Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans
JA Beckman et al.
CIRCULATION (2001)
Glucose tolerance and cardiovascular mortality -: Comparison of fasting and 2-hour diagnostic criteria
K Borch-Johnsen et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
分享论文
